Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Dr Pepper Reacquires Distribution Rights For Certain Brands In Asia-Pacific

RELATED NEWS
Trade DPS now with 

Dr Pepper Snapple Group (DPS: Quote) announced it has reached an agreement with Mondeléz International, Inc. to reacquire the distribution rights for Snapple and several other non-carbonated beverage brands in parts of Asia-Pacific.

Terms of the agreement were not disclosed. The company said it does not anticipate the acquisition to have any material effect on its 2013 financial results.

The company will have the rights to distribute Snapple in Australia, Malaysia, Singapore, China, Hong Kong, Japan and South Korea. In Australia, the company also will have distribution rights for Mott's, Mr & Mrs T, Clamato, Mistic, Holland House and Yoo-hoo.

Click here to receive FREE breaking news email alerts for Dr. Pepper Snapple Group, Inc. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Suggesting that the economy is gaining traction, the Conference Board released a report on Thursday showing a bigger than expected increase by its index of leading U.S. economic indicators in July. Results of a survey released by the Federal Reserve Bank of Philadelphia on Thursday showed that regional manufacturing activity unexpectedly grew at an accelerated rate in the month of August, with the index of activity in the sector reaching a three-year high. Existing home sales in U.S. unexpectedly rose to a ten-month high in the month of July, according to a report released by the National Association of Realtors on Thursday. NAR said existing home sales climbed to a seasonally adjusted annual rate of 5.15 million in July from a downwardly revised 5.03 million in June.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.